If you have two faulty copies of the CFTR gene, you will have cystic fibrosis. But the severity of your disease will depend on environmental factors and many other genes. Locating these genes and altering their function could ...
Sep 29, 2015
0
95
Scientific experiments examining what happens to the faulty channel protein that causes cystic fibrosis during inflammation have yielded unexpected and exciting results. The study, conducted by Sara Bitam and her colleagues ...
Sep 2, 2015
0
693
Treatments for the same opportunistic bacteria found in cystic fibrosis patients can work in one area in the lung and be less effective in others. The reason, reported August 20 in Cell Host & Microbe, is that bacteria become ...
Aug 20, 2015
0
9
An experimental cystic fibrosis drug has been shown prevent the disease's damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Jul 14, 2015
0
94
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
Jul 3, 2015
0
200
Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...
Jul 2, 2015
0
9
Cystic fibrosis is more deadly for Hispanic than non-Hispanic patients, a disparity that is not explained by differences in their access to health care, according to a new study from the Stanford University School of Medicine.
Jun 24, 2015
0
7
A new drug screening technology developed at the Harvard T.H. Chan School of Public Health has identified a new potential anti-diabetes compound—and a powerful way to quickly test whether other molecules can have a positive ...
Jun 17, 2015
0
70
The five-year survival rate for Canadians with cystic fibrosis who have received a lung transplant is 67 per cent and half of those who have had transplants live beyond 10 years, new research has found.
Jun 15, 2015
0
135
A novel two-drug combination has the potential to target and restore a defective protein underlying cystic fibrosis (CF), according to two phase III clinical trials conducted at 187 medical centers around the world, including ...
May 27, 2015
0
8
